Eiger BioPharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2014 to Q1 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2014 to Q1 2024.
  • Eiger BioPharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending April 4, 2024 was 1.48M shares, a 96.6% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 1.48M -42.7M -96.6% Apr 4, 2024 10-K 2024-04-08
Q3 2023 44.4M +310K +0.7% Nov 6, 2023 10-Q 2023-11-09
Q2 2023 44.3M +330K +0.75% Aug 9, 2023 10-Q 2023-08-14
Q1 2023 44.2M +9.52M +27.5% Mar 13, 2023 10-K 2023-03-17
Q3 2022 44.1M +10.1M +29.7% Nov 1, 2022 10-Q 2022-11-03
Q2 2022 44M +10M +29.5% Aug 1, 2022 10-Q 2022-08-04
Q1 2022 34.6M +738K +2.18% Mar 7, 2022 10-K 2022-03-10
Q3 2021 34M +1.44M +4.44% Nov 1, 2021 10-Q 2021-11-04
Q2 2021 34M +4.71M +16.1% Aug 2, 2021 10-Q 2021-08-05
Q1 2021 33.9M +9.34M +38% Mar 5, 2021 10-K 2021-03-09
Q3 2020 32.5M +8.04M +32.8% Nov 2, 2020 10-Q 2020-11-05
Q2 2020 29.2M +4.8M +19.6% Aug 3, 2020 10-Q 2020-08-06
Q1 2020 24.6M +5.3M +27.5% Mar 5, 2020 10-K 2020-03-13
Q3 2019 24.5M +5.4M +28.3% Nov 4, 2019 10-Q 2019-11-07
Q2 2019 24.4M +10.2M +71.6% Aug 5, 2019 10-Q 2019-08-08
Q1 2019 19.3M +8.73M +83% Mar 11, 2019 10-K 2019-03-14
Q3 2018 19.1M +8.58M +81.6% Nov 5, 2018 10-Q 2018-11-09
Q2 2018 14.2M +5.88M +70.2% Aug 6, 2018 10-Q 2018-08-10
Q1 2018 10.5M +2.17M +25.9% Mar 2, 2018 10-K 2018-03-09
Q3 2017 10.5M +2.16M +25.8% Nov 3, 2017 10-Q 2017-11-09
Q2 2017 8.37M +1.26M +17.8% Aug 3, 2017 10-Q 2017-08-11
Q1 2017 8.36M +1.42M +20.4% Mar 16, 2017 10-K 2017-03-23
Q3 2016 8.36M -15.6M -65.1% Nov 3, 2016 10-Q 2016-11-08
Q2 2016 7.1M -16.8M -70.3% Aug 4, 2016 10-Q 2016-08-10
Q1 2016 6.95M -16.9M -70.9% Mar 31, 2016 10-Q 2016-05-16
Q3 2015 23.9M +611K +2.62% Oct 31, 2015 10-Q 2015-11-09
Q2 2015 23.9M +5.38M +29% Jul 31, 2015 10-Q 2015-08-11
Q1 2015 23.8M +5.33M +28.8% Mar 13, 2015 10-K 2015-03-31
Q3 2014 23.3M Oct 31, 2014 10-Q 2014-11-12
Q2 2014 18.5M Jul 28, 2014 10-Q 2014-08-07
Q1 2014 18.5M Apr 25, 2014 10-Q 2014-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.